Iirimaa - inglise - HPRA (Health Products Regulatory Authority)

reckitt benckiser ireland ltd - ibuprofen - prolonged-release tablet - ibuprofen

Austraalia - inglise - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - macrogol 3350, quantity: 13125 mg; sodium chloride, quantity: 350.7 mg; potassium chloride, quantity: 46.6 mg; sodium bicarbonate, quantity: 178.5 mg - powder, oral - excipient ingredients: acesulfame potassium - for effective relief from constipation, treatment of constipation, and treatment of faecal impaction defined as refractory constipation with faecal loading of the rectum and/or colon confirmed by the physical examination of the abdomen and rectum, in adults and children 12 years and over.

Uus-Meremaa - inglise - Medsafe (Medicines Safety Authority)

carsl consulting - macrogol 3350 13.125 g;  ;  ;  ;  ; potassium chloride 46.6mg;  ;  ; sodium bicarbonate 178.5mg;  ; sodium chloride 350.7mg;  ;  ;   - powder for oral solution - active: macrogol 3350 13.125 g         potassium chloride 46.6mg     sodium bicarbonate 178.5mg   sodium chloride 350.7mg       excipient: acesulfame potassium lime & lemon flavour trusil 463842 - for effective relief from constipation, treatment of chronic constipation. movicol is also effective in resolving faecal impaction, defined as refractory constipation with faecal loading of the rectum and/or colon confirmed by physical examination of abdomen and rectum.

Suurbritannia - inglise - MHRA (Medicines & Healthcare Products Regulatory Agency)

formula a) (thornton & ross ltd - white soft paraffin; cetostearyl alcohol; macrogol cetostearyl ether 22; liquid paraffin; chlorocresol; purified water - cutaneous cream - 150mg/1gram ; 72mg/1gram ; 18mg/1gram ; 60mg/1gram ; 1mg/1gram ; 699mg/1gram

Belgia - inglise - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

eg sa-nv - potassium chloride 46,6 mg; sodium chloride 350,7 mg; macrogol 13125 mg; sodium hydrogen carbonate 178,5 mg - powder for oral solution - 13,7 g - sodium chloride 350.7 mg; potassium chloride 46.6 mg; sodium bicarbonate 178.5 mg; macrogol 3350 13125 mg - macrogol, combinations

Belgia - inglise - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

eg sa-nv - sodium hydrogen carbonate 89,25 mg; macrogol 6562,5 mg; potassium chloride 23,3 mg; sodium chloride 175,35 mg - powder for oral solution - 6,9 g - sodium bicarbonate 89.25 mg; sodium chloride 175.35 mg; potassium chloride 23.3 mg; macrogol 3350 6562.5 mg - macrogol, combinations

Suurbritannia - inglise - MHRA (Medicines & Healthcare Products Regulatory Agency)

galen ltd - sodium; chloride; potassium; bicarbonate; macrogol '3350' - powder for oral solution - 65mmol/1litre ; 53mmol/1litre ; 5.4mmol/1litre ; 17mmol/1litre ; 105gram/1litre

Austraalia - inglise - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - sodium chloride, quantity: 175.35 mg; macrogol 3350, quantity: 6562.5 mg; sodium bicarbonate, quantity: 89.25 mg; potassium chloride, quantity: 23.3 mg - powder, oral - excipient ingredients: acesulfame potassium - for effective relief from constipation and treatment of chronic constipation in adults and children aged 2 years and older. for resolving faecal impaction, defined as refractory constipation with faecal loading of the rectum, or the rectum and colon, confirmed by physical examination of abdomen and rectum, in adults and children 2 years and older. for prevention of recurrence of faecal impaction in children aged 2 years and older. use in children 2 years and older should be limited to 12 weeks except under medical supervision.

Austraalia - inglise - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - sodium chloride, quantity: 350.7 mg; sodium bicarbonate, quantity: 178.5 mg; potassium chloride, quantity: 46.6 mg; macrogol 3350, quantity: 13125 mg - powder, oral - excipient ingredients: acesulfame potassium; flavour - for effective relief from constipation, treatment of constipation, and treatment of faecal impaction defined as refractory constipation with faecal loading of the rectum and/or colon confirmed by the physical examination of the abdomen and rectum, in adults and children 12 years and over.

Austraalia - inglise - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - sodium chloride, quantity: 175.35 mg; sodium bicarbonate, quantity: 89.25 mg; potassium chloride, quantity: 23.3 mg; macrogol 3350, quantity: 6562.5 mg - powder, oral - excipient ingredients: acesulfame potassium; flavour - for effective relief from constipation and treatment of chronic constipation in adults and children aged 2 years and older. for resolving faecal impaction, defined as refractory constipation with faecal loading of the rectum, or the rectum and colon, confirmed by physical examination of abdomen and rectum, in adults and children 2 years and older. for prevention of recurrence of faecal impaction in children aged 2 years and older. use in children 2 years and older should be limited to 12 weeks except under medical supervision.